Pharmaceutical

Arcturus Therapeutics extends cystic fibrosis treatment deal

Arcturus Therapeutics has extended an existing agreement in place with the Cystic Fibrosis Foundation (CF Foundation) for advancing ARCT-032.

Sep 27, 2023 - 20:00
Arcturus Therapeutics extends cystic fibrosis treatment deal
Arcturus Therapeutics has extended an existing agreement in place with the Cystic Fibrosis Foundation (CF Foundation) for advancing ARCT-032.
Read the original article

Tags:

Previous Article

UKHSA signs influenza vaccine deal with CSL Seqirus

Next Article

MilliporeSigma opens two new mRNA manufacturing facilities in Germany

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu for solid tumours

FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu for s...

Apr 9, 2024

STAT+: The biotech scorecard for the fourth quarter: 16 stock-moving events to watch

STAT+: The biotech scorecard for the fourth quarter: 16...

Oct 2, 2023

New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval

New nasal spray to reverse fentanyl and other opioid ov...

May 23, 2023